Is orforglipron available, and how much does it cost in 2026?

Foundayo (orforglipron) is FDA approved and available in the United States in 2026. Lilly began accepting prescriptions through LillyDirect in April, with a listed self-pay starting price of $149 per month and eligible commercially insured patients potentially paying $25 per month. Actual eligibility, dose, and cost depend on the prescription and coverage.

What changed in 2026

Orforglipron is an oral GLP-1 medicine for chronic weight management. Unlike injectable GLP-1 medicines, it is taken as a pill, and Lilly says it can be taken without food or water restrictions. FDA approval does not mean it is appropriate for everyone. A licensed prescriber still needs to evaluate contraindications, interactions, pregnancy plans, and possible gastrointestinal side effects.

What the launch prices mean

The $149 figure is a manufacturer self-pay starting price, not a promise that every dose or pharmacy will cost that amount. The $25 commercial-coverage figure depends on eligibility rules. People with Medicare, Medicaid, or other government insurance may face different terms. Verify the current cash price and coverage before choosing a telehealth membership.

How to compare telehealth access

Ask whether a provider prescribes Foundayo, whether medication is included in its membership fee, and how follow-up or dose adjustments are handled. A low platform fee can still lead to a higher total cost when medication is billed separately. ClearlyMeds recommends comparing the provider fee, medication price, follow-up care, and cancellation terms together.

ClearlyMeds bottom line

Orforglipron is no longer merely a future drug: Foundayo is an FDA-approved oral GLP-1 option in 2026. Its headline self-pay price starts at $149 per month, but the price a patient actually pays can vary. Confirm current availability and total monthly cost with the prescriber and dispensing pharmacy.